Cronos Group Inc. Amends 8-K Filing

TL;DR

Cronos Group (CRON) filed an 8-K/A amendment on June 20, 2024, related to shareholder votes. Nothing major changed, just a procedural update.

AI Summary

Cronos Group Inc. filed an 8-K/A on July 22, 2024, to amend a previous filing regarding a submission of matters to a vote of security holders. The earliest event reported in this amendment was on June 20, 2024. The company, previously known as PharmaCan Capital Corp. until October 21, 2015, is incorporated in British Columbia, Canada, with its principal executive offices located in Toronto, Ontario.

Why It Matters

This amendment to a previous filing indicates a procedural update or correction by Cronos Group Inc. regarding matters submitted for a shareholder vote, which could be relevant for investors tracking corporate governance actions.

Risk Assessment

Risk Level: low — This filing is an amendment to a previous report and does not introduce new material events or financial changes.

Key Players & Entities

• Cronos Group Inc. (company) — Registrant
• PharmaCan Capital Corp. (company) — Former company name
• June 20, 2024 (date) — Earliest event reported date
• July 22, 2024 (date) — Filing date
• October 21, 2015 (date) — Date of name change
• 111 Peter Street, Suite 300 Toronto, Ontario M5V 2H1 (address) — Principal executive offices

FAQ

From the Filing

0001656472-24-000080.txt : 20240722 0001656472-24-000080.hdr.sgml : 20240722 20240722163205 ACCESSION NUMBER: 0001656472-24-000080 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240620 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240722 DATE AS OF CHANGE: 20240722 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 241131891 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 8-K/A 1 cron-20240620.htm 8-K/A cron-20240620 true CRONOS GROUP INC. 0001656472 Toronto Canada 001-38403 Ontario 0001656472 2023-11-08 2023-11-08 0001656472 2024-06-20 2024-06-20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 111 Peter Street, Suite 300 Toronto , Ontario M5V 2H1 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 416 ) 504-0004 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Shares, no par value CRON The NASDAQ Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Cronos Group Inc. (the “Company”) is filing this Form 8-K/A as an amendment to the Current Report on Form 8-K filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on June 21, 2024. Item 5.07.    Submission of Matters to a Vote of Security Holders. On July 19, 2024, the Company reconvened its 2024 Annual Meeting of Shareholders (the “Meeting”), which was adjourned on June 20, 2024. The proposal voted upon at the reconvened Meeting and the final results of the shareholder vote on the proposal are set forth below. The proposal is summarized